205 related articles for article (PubMed ID: 32742516)
1. Proposing a Model for the National Hemovigilance Information System in Iran.
Asadi F; Ramezanghorbani N
J Med Life; 2020; 13(2):211-218. PubMed ID: 32742516
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
[TBL] [Abstract][Full Text] [Related]
3. The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System.
Kasraian L; Karimi MH
Hemoglobin; 2015; 39(4):274-80. PubMed ID: 26036919
[TBL] [Abstract][Full Text] [Related]
4. How is national recipient hemovigilance conducted in the United States?
Chung KW; Harvey A; Basavaraju SV; Kuehnert MJ
Transfusion; 2015 Apr; 55(4):703-7. PubMed ID: 25565577
[TBL] [Abstract][Full Text] [Related]
5. Delayed hemolytic transfusion reaction in the French hemovigilance system.
Rieux C; Brittenham G; Bachir D; De Meyer E; Boudjedir K;
Transfus Clin Biol; 2019 May; 26(2):109-111. PubMed ID: 30910456
[TBL] [Abstract][Full Text] [Related]
6. Investigating the quality of hemovigilance process using the first two steps of Six Sigma model: a cross-sectional study.
Molaahmadi-Hassanabadi F; Mehrolhassani MH; Rahimisadegh R
BMC Health Serv Res; 2023 Oct; 23(1):1169. PubMed ID: 37891622
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022.
Chavez Ortiz JL; Griffin I; Kazakova SV; Stewart PB; Kracalik I; Basavaraju SV
Transfusion; 2024 Apr; 64(4):627-637. PubMed ID: 38476028
[TBL] [Abstract][Full Text] [Related]
8. Thirty years of hemovigilance - Achievements and future perspectives.
Vuk T; Politis C; Laspina S; Lozano M; Haddad A; de Angelis V; Garraud O;
Transfus Clin Biol; 2023 Feb; 30(1):166-172. PubMed ID: 36216308
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
[TBL] [Abstract][Full Text] [Related]
10. [Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network].
Rieux C; De Meyer E; Boudjedir K
Transfus Clin Biol; 2015 Mar; 22(1):37-41. PubMed ID: 25441454
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
[TBL] [Abstract][Full Text] [Related]
12. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
[TBL] [Abstract][Full Text] [Related]
14. [Implementation of hemovigilance in Sub-Saharan Africa].
Dahourou H; Tapko JB; Nébié Y; Kiénou K; Sanou M; Diallo M; Barro L; Murphy E; Lefrère JJ
Transfus Clin Biol; 2012 Feb; 19(1):39-45. PubMed ID: 22296906
[TBL] [Abstract][Full Text] [Related]
15. Incorporating the entity of under-transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory.
Rajbhandary S; Andrzejewski C; Fridey J; Stotler B; Tsang HC; Hindawi S; Reddy O; Medina MC; Razatos A; Narayan S; Fung M
Transfusion; 2022 Mar; 62(3):540-545. PubMed ID: 35044688
[TBL] [Abstract][Full Text] [Related]
16. Transfusion and hemovigilance in pediatrics.
Bolton-Maggs PH
Pediatr Clin North Am; 2013 Dec; 60(6):1527-40. PubMed ID: 24237986
[TBL] [Abstract][Full Text] [Related]
17. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
Dhiman Y; Raturi M; Kala M; Kusum A
Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
[TBL] [Abstract][Full Text] [Related]
18. Hemovigilance and the Notify Library.
Whitaker BI; Strong DM; Gandhi MJ; Petrisli E
Immunohematology; 2017 Dec; 33(4):159-164. PubMed ID: 29378148
[TBL] [Abstract][Full Text] [Related]
19. Transfusion reaction reporting in the era of hemovigilance: where form meets function.
Dunbar NM; Walsh SJ; Maynard KJ; Szczepiorkowski ZM
Transfusion; 2011 Dec; 51(12):2583-7. PubMed ID: 21745209
[TBL] [Abstract][Full Text] [Related]
20. [International databases: usefulness and limitations in hemovigilance].
Wiersum-Osselton JC
Transfus Clin Biol; 2010 Dec; 17(5-6):306-9. PubMed ID: 21055991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
